Resource

Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for global trials. The document highlights how professional language services, such as those provided by TransPerfect Life Sciences, can offer solutions to ensure accurate and effective implementation of COAs...

Resource

LifeSci Talks COA Series | Licensing Challenges vs. eCOA Vendor Capabilities

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials...

Resource

Accelerating Clinical Product Development through Centralized Content Work Streams

As more and more clinical trials are conducted internationally, with a higher level of protocol complexity, and with increased competition to get medical products to market faster globally, the need for efficient and streamlined clinical product development is greater than ever. Many clinical teams have experienced delays or bottlenecks in their programs as a result of not getting accurate local-language documentation to sites quickly enough. With companies working to...

Resource

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & CEO of Aparito, in conversation with Mark Wade, Global Practice Leader at TransPerfect Life Sciences, as they discuss: - The disparity in data capture for pediatric populations. - Considerations...

Resource

A Checklist for eCOA Solution Deployment: Best Practices and Considerations

Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the process. Download our whitepaper to learn about the eCOA landscape today, and access a checklist that walks through each of the essential factors to consider so you can be confident your eCOA...

Medical Device Solutions

TransPerfect Medical Device Solutions is the first supplier to combine ISO 13485, 14971, and 9001 certified, patented language services with validated process automation technologies to meet the content management challenges of evolving regulations. ...

Resource

Successful English Build & Language Migration

Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the digital era, shifting to electronic Clinical Outcome Assessments (eCOAs) is becoming more critical than ever. However, it is imperative that the migration of COAs to an electronic format is error...

Resource

The Clinical Trial Website Localization Buyer’s Guide

Every week a recruitment page isn't live in the right language is a week of enrollment you're not getting back. Selecting a website localization solution is more than a technology decision — it's a question of how fast your team can move, how much IT burden you're willing to carry, and whether your workflow can survive a protocol amendment. This guide breaks down…...

Resource

Prepared, Not Overbuilt: How Smart Life Sciences Organizations Set Themselves Up for Commercialization, Global Partnerships, Licensing, and IPOs

The reality of most early-stage start up teams is that they are doing ten jobs at once. But waiting too long to organize documentation, content, and operations can slow everything down when it matters most. This guide shares how lean life sciences organizations prepare for commercialization and partnerships without overengineering their workflows....

Resource

MDR and IVDR Timeline Overview

In order to take advantage of the MDD extension, device manufacturers must comply with several near-term deadlines and plan for long regulatory turnarounds – the extension provides less time than you might think! Learn how TransPerfect can help you meet the impending MDR and IVDR deadlines with intelligent automation solutions for labeling, SSCPs, SSPs, marketing and other regulated content by downloading our MDR/IVDR deadlines cheat sheet!...

Resource

6 Pathways to Take Your MT Strategy to the Next Level in 2024

With 2024 well underway, innovators in the global life sciences and pharmaceutical industries continue to question how to maximize efficiencies and reduce complexities in clinical and regulatory content development and localization. As part of the broader technological roadmap, AI and automation remain front and center as key players in taking these workflows to new heights. Machine translation (MT) is expected to directly impact and transform approaches to multilingual...